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Abstract: Hydration is important post-renal transplant to maintain
adequate renal perfusion and graft function. Adherence to fluid
recommendations is challenging given barriers to staying hydrated.
There are no studies of adherence to fluid intake recommendations
following pediatric renal transplant. Through this pilot study, we
sought to determine whether the use of a commercially available
interactive water bottle would lead to better adherence to
recommended fluid intake and improved kidney functioning post-
transplant relative to standard of care. Participants included 32 youth
ages 7–19 ≥1 month post-kidney transplant randomized to the
intervention (HydraCoach water bottle) or standard education
control group. Laboratory records were reviewed for serum chemistries
(Na, BUN, creatinine) at baseline and one-month follow-up, and
participants recorded daily fluid intake for 28 days. Those in the
intervention group were significantly more likely to meet or exceed their
fluid target, but this did not translate into better kidney functioning.
Participants in the intervention group largely reported satisfaction with
the water bottle and were likely to continue its use. While an interactive
water bottle providing real-time feedback may be a promising
intervention to help pediatric kidney transplant patients meet fluid
goals, it did not appear to impact kidney function.
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Adequate hydration is believed to be important
following renal transplant in order to maintain
renal perfusion. As such, staying well hydrated is
one of many self-care practices required of post-
renal transplant recipients. Recommendations
for high levels of fluid intake are typically given
post-transplant as part of what patients are
expected to do to maintain the health of their
graft. In the adult renal transplant population,
however, there are inconsistent data supporting
this practice. While one study found fluid intake
to be related to better graft function in the early
months post-transplant (1), another found no
such benefit a year post-transplant (2). With no
empirical studies either supporting or refuting
the impact of fluid intake on graft function fol-
lowing pediatric renal transplant, the recommen-
dation for high fluid intake remains a standard
of care.
Adherence to fluid intake is understudied in
the pediatric literature despite the fact that rec-
ommendations for fluid intake are thought to be
an integral part of renal post-transplant manage-
ment as well as in the management of other pedi-
atric conditions such as constipation, obesity,
migraine, and sickle-cell disease. Studies in other
populations where fluid intake is important sug-
gest that adhering to hydration recommenda-
tions is challenging. For example, Kuhl, Felt,
and Patton (3) reported that less than half of
children with retentive encopresis met their fluid
goals. Results from the adult renal transplant
population echo these challenges with only about
one-third of adult renal transplant recipients
Abbreviations: BSA, body surface area; BUN, blood urea
nitrogen; PI, primary investigator.
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being adherent to required fluid intake volumes
(4). Adherence to fluid recommendations is very
difficult given the high fluid volumes required
post-transplant (2).
While there is a better understanding of the
challenges managing immunosuppressant medi-
cation following pediatric renal transplant (5),
little is known about how youth manage their
recommended fluid intake goals or what barriers
youth face when trying to adhere to their fluid
targets. In fact, aside from medication adherence,
little is known about adherence to other aspects
of the pediatric post-transplant medical regimen.
In adults, not feeling thirsty, forgetting to drink,
and not having the preferred fluids available are
reported as interfering with adherence to fluid
goals (4). We can assume that youth would expe-
rience similar challenges, especially as these bar-
riers are common in pediatric non-adherence (6).
Interventions that target these and other issues
related to fluid intake could be hypothesized to
improve fluid adherence.
We are proposing this study to see whether the
use of an interactive, commercially available
water bottle (HydraCoach) improves adherence
to fluid intake goals in the post-transplant pedi-
atric population relative to current standard-of-
care education practices. It is hypothesized that
the use of this interactive bottle may address
some of the challenges reported by adult trans-
plant recipients by having fluids readily avail-
able, being able to track fluid intake, and having
the bottle give feedback on achievement of target
fluid goals. We hypothesized that the interven-
tion group would show better fluid intake adher-
ence and better serum chemistries than the
control group. This study has significant rele-
vance to the care of the pediatric kidney
transplant population, as adherence to post-
transplant fluid intake guidelines is believed to be
important for good post-transplant kidney
health and graft outcomes.
Methods
Participants >5 yr of age (M = 13.8 yr [s.d. = 3.4], range
7–19 yr) and more than one month post-kidney transplant
(M = 51.3 months [s.d. = 45.7]; range 1–155 months post-
transplant) were recruited from the kidney transplant clinic
of St. Louis Children’s Hospital. Exclusion criteria included
if the family did not speak English or if the child’s cognitive
functioning would interfere with their ability to participate.
We had a targeted enrollment of 40 participants with 20 in
each arm of the study based on our convenience sample of
all eligible patients in our clinic; a total of 32 families partic-
ipated. Eight families refused to participate with reasons
given including being too busy, believing it would be too dif-
ficult to track at day care, and fear that their nurse coordina-
tor would find out how much they were actually drinking.
Eighty-eight percent of the sample was Caucasian American
and 44% were female.
Potential participants were notified of the study by an
introductory letter prior to a scheduled routine clinic visit
(Time 1). Informed consent was obtained from the partici-
pant’s parent or caregiver and assent from the participant,
after explanation of the study by the PI or a designee at the
clinic visit. This study was approved by the IRB at Wash-
ington University School of Medicine.
Participants were randomized to either the intervention
(HydraCoach water bottle) or control (standard-of-care
education regarding fluid intake) group using a block ran-
domization strategy based on week of clinic visit. This
allowed all patients in a given clinic week to be enrolled in
one arm of the study. We chose this method to keep partici-
pants in different arms of the study from comparing infor-
mation or adherence strategies that could impact study
outcomes. As a result, participants were not blind to group
membership.
The HydraCoach water bottle (Fig. 1) is an interactive
water bottle that calculates personal hydration needs, tracks
real-time fluid consumption, and monitors fluid intake pac-
ing through the day (www.hydracoach.com). It is commer-
cially available and can be purchased for <$30. The
HydraCoach is easy to use and program via the small
removable computer on the bottle. A person merely enters
their weight and the bottle automatically calculates a target
fluid intake goal for that person. This can also be easily
adjusted manually for a higher or lower fluid target. The
HydraCoach also prompts the user to drink by continu-
ously visually displaying the percentage consumed in either
liters or ounces. It displays total amount consumed in a 24-
h period and can be easily reset every 12–24 h by the push
of a few buttons. The display flashes after the 24-h period to
remind the user to reset it.
Participants randomized to the intervention group
received the HydraCoach water bottle after being
instructed on its use, and could keep the water bottle for
Fig. 1. HydraCoach water bottle .
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their personal use at the end of the study. Those ran-
domized to the standard care group (control) received
the HydraCoach water bottle for their personal use only
after completion of the four-wk study. The study authors
have no financial or other relationship with Hydra-
Coach.
All participants were asked to recall their fluid intake
for the three days prior to the start of the study via a log
that was included on the recruitment letter or on a form
provided in clinic. After enrollment, participants were
provided with a daily target fluid intake, based on their
body size (1500 mL/m2 BSA), and received written infor-
mation regarding appropriate fluid choices. Participants
randomized to the intervention group were instructed on
its use after the appropriate daily target was programmed
into the device by a study team member. A diary was
provided for every participant to record daily fluid intake
over a period of the four wk following their enrollment in
the study.
After one month, when the child returned for their regu-
larly scheduled clinic appointment, the daily diaries of each
participant were collected for analysis (Time 2). All parents
and youth ages 10 and above in the intervention group com-
pleted a satisfaction survey to get feedback on their percep-
tions of the water bottle. Participants randomized to
standard-of-care control group received a HydraCoach
water bottle for their participation in the study and were
instructed on its use; those who were randomized to the
intervention group could keep the HydraCoach for per-
sonal use at the end of the study.
Clinical laboratory records were reviewed for partici-
pant’s serum chemistries at baseline (Time 1) and at study
end (one month later—Time 2), for electrolytes (Na), BUN,
and creatinine. This laboratory information was gathered as
part of the patient’s standard of care.
Data analysis plan
All data were analyzed using SAS v9.3. Descriptive statistics
including frequencies, means, medians, and standard devia-
tions were used to describe the sample. Age and time since
transplant were compared between control and intervention
groups using Wilcoxon rank-sum tests. Differences in fluid
achieved from goal and sodium, BUN and creatinine levels
from Time 1 to Time 2 were computed and compared using
the Wilcoxon rank-sum test. These differences were also
assessed between the control and intervention group con-
trolling for time since transplant using linear regression.
Logistic regression was used to assess the association
between meeting or exceeding fluid target and group con-
trolling for time since transplant.
Results
Fluid intake
There was a significant difference (p = 0.011) in
median time since transplant between the control
(5.83 yr [range 0.81–12.94]) and intervention
groups (1.75 yr [range 0.08–5.96]). There was no
significant difference in age between the groups
(p = 0.40; control group M = 14.44 yr,
s.d. = 2.68; intervention group M = 13.19 yr,
s.d. = 3.92). For the entire study sample, 63%
tracked their fluid intake using the fluid diary.
There was no significant difference in tracking by
group (p = 0.72); however, there was a lower
percentage of the intervention group tracking
(56.3%, n = 9/16) vs. the control group (68.8%,
n = 11/16).
Participants reported fluid intake as a group
ranged from 61% below target to 98% above
target. There was a significant univariate differ-
ence between the difference in fluid intake at
Time 2 and fluid goal between control and inter-
vention groups p = 0.029 (Table 1). Those in the
control group generally did not meet their fluid
goal, with a median difference in Time 2 average
fluid intake and fluid goal being 14.32 ounces
(range 49.79 to 65.69 ounces) compared to
those in the intervention group, who generally
exceeded their fluid goal (median difference of
28.58 ounces with a range of 10.86 to 60.71
ounces). Controlling for time since transplant
(which was not a significant predictor of change
in fluid, p = 0.86), a similar trend was seen, but it
is not statistically significant (p = 0.077). Specifi-
cally, the intervention group had an expected dif-
ference in fluid intake from goal of 28.31 ounces
more than the control group. This lack of signifi-
cance is likely due to the small sample size and
lack of power to detect such a difference (even
though there are 32 participants, lack of Time 2
fluid data decreased the sample size down to 19
in the regression equation).
If we consider the dichotomous outcome of
whether or not the fluid goal was reached at
Table 1. Median levels (ranges) of changes in fluid and laboratory values by group
Variable
Control (n = 16) Intervention (n = 16)
p-Valuen Median (range) n Median (range)
Fluid achieved-fluid goal (oz) 11 14.32 (49.79–65.69) 8 28.58 (10.86–60.71) 0.029
Fluid achieved-fluid at time 1 (oz) 6 7.64 (13.77 to 6.69) 3 5.50 (2.69–5.81) 0.028
Percent change in BUN 16 4.56 (31.25–107.33) 16 2.38 (36.84–61.54) 0.78
Percent change in sodium 15 0.72 (3.52–2.19) 16 0 (4.86–1.45) 0.29
Percent change in creatinine 16 7.74 (16.67–44.44) 16 8.39 (18.18–66.67) 0.53
p-Value is from Wilcoxon rank-sum tests without controlling for time since transplant.
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Time 2 as opposed to the exact change in fluid
intake, nearly 90% of the intervention group met
or exceeded their fluid goal, while <40% of the
control group reportedly met or exceeded their
fluid goal. Controlling for time from transplant,
the intervention group had borderline significant
higher odds of reaching or exceeding their goal
with an odds ratio of 2.56 (95% CI 0.95–177.97,
p = 0.055) and time from transplant was not
significantly associated with the outcome
(p = 0.91). If you remove time from transplant
from the model, the intervention is significantly
associated with the odds of meeting the fluid goal
(OR 12.25, 95% CI 1.08–138.99, p = 0.043). The
wide confidence intervals are due to the small
sample size.
Laboratory outcomes
Univariately, the percent change in BUN
(p = 0.78), sodium (p = 0.29), and creatinine
(p = 0.53) from Time 1 to Time 2 did not differ
significantly between groups. A positive percent
change indicates an increase in the level from
Time 1 to Time 2, whereas a negative percent
change indicates a decrease in the level over time.
The median percent change in BUN for the con-
trol group was 4.56% (range 31.25% to
107.33%) and for the intervention group
2.38% (range 36.84 to 61.54%). The median
percent change in sodium for the control group
was 0.72% (range 3.52% to 2.19%) and for
the intervention group was 0% (range 4.86%
to 1.45%). The median percent change in creati-
nine for the control group was 7.74% (range
16.67 to 44.44%), and for the intervention
group, the median percent change was 8.39%
(range 18.18 to 66.67%).
There was an outlier in the control group
whose BUN level doubled from Time 1 to Time
2 and has the longest time from transplant to
enrollment (12.9 yr). The significance of time
since transplant differs depending on including
this participant or not into regression analysis
for BUN, but either way, being in the interven-
tion group was not significantly associated with
percent change in BUN. There was no significant
association between intervention group and per-
cent change of sodium when controlling for time
from transplant. For changes in creatinine, time
from transplant was borderline significant such
that a one-yr increase in time from transplant
increased the expected percentage change in cre-
atinine by 1.87%, s.e. = 0.94, p = 0.057, and
there was a trend for the intervention group to
have higher percent change in creatinine
(12.40%, s.e. = 7.07, p = 0.09).
Satisfaction
Satisfaction survey results completed by the
intervention group are presented in Table 2.
Results suggest that the intervention group was
largely satisfied with the HydraCoach water
bottle and 67% agreed it was easy to use. How-
ever, only 50% of participants reported using the
water bottle every day, 16.7% a few days, and a
third reported using the water bottle only a few
days. Over 50% felt that use of the water bottle
improved their fluid intake. Half of the partici-
pants agreed they would continue to use the
water bottle after study completion and 83%
reported they felt comfortable using the water
bottle around friends.
Discussion
This pilot study is the first to attempt to address
the challenges of fluid adherence following pedi-
atric renal transplant. Using a commercially
available water bottle that provided feedback on
intake, we hoped to alleviate some of the chal-
lenges inherent in adhering to post-transplant
fluid goals. Our goal was to provide an afford-
able and accessible intervention that would
improve fluid adherence and lead to improved
serum chemistries beyond the standard-of-care
clinic education. While the intervention did not
Table 2. Satisfaction with intervention (n = 12)
Item
Strongly
agree Agree Disagree
Strongly
disagree
Don’t know/
blank
The HydraCoach water bottle was easy to use 25.0% 41.7% 16.7% 8.3% 8.3%
The HydraCoach water bottle helped increase water intake 8.3% 50.0% 33.3% 8.3% 0.0%
The child felt comfortable using the HydraCoach water
bottle around friends
16.7% 66.7% 8.3% 0.0% 8.3%
The child will continue to use this bottle after the study is over 16.7% 33.3% 16.7% 8.3% 25.0%
Almost every day Most days A few days
My child used the HydraCoach water bottle 50.0% 16.7% 33.3%
38
Kullgren et al.
appear to significantly impact serum chemistries
during the brief intervention, it remains a prom-
ising strategy that may enhance fluid adherence
for some individuals post-transplant as the inter-
vention did improve overall fluid intake relative
to the individual’s fluid goal. Although there was
a significant difference in the time since trans-
plant between the control and intervention
group, this factor was not significantly associated
with meeting or exceeding their fluid goal.
As a pilot study, we hoped to collect as much
useful information as possible, from a majority
of our clinic transplant population, without
being unduly burdensome to participants or
clinic staff. The four-wk study duration corre-
sponded to the typical clinic and laboratory test-
ing schedules of the participants. Block
randomization of all participants in a given
weekly clinic simplified participant education
and training, while minimizing “cross talk”
between intervention and standard care partici-
pants regarding fluid intake. With this approach,
we were successful in recruiting 80% of the eligi-
ble transplant recipients. Despite several inter-
ventions to encourage recording of daily fluid
intake, incomplete fluid diaries before and during
the study period were a significant problem.
Other study designs, such as crossover with each
participant acting as their own control with and
without the intervention bottle, may provide
more definitive results; however, documenting
daily fluid intake will likely remain as a chal-
lenge. Additionally, future researchers may con-
sider stratification of participants based on time
since transplant to minimize the impact of this
important factor on outcomes.
While a few epidemiologic studies (7) suggest
increased fluid intake in the general population
may protect from chronic kidney disease, it
remains unclear, however, whether this behavior
translates into better long-term allograft function
post-transplant. In the current study, partici-
pants who documented higher fluid intakes did
not show any clinically significant changes in lab-
oratory values, and in fact, a slight increase in
creatinine was noted in the intervention group.
Although this increase was statistically signifi-
cant, it is of unclear clinical importance and may
be related to the age of the graft. An elevated
plasma creatinine in a kidney transplant patient
may reflect acute rejection, calcineurin inhibitor
(cyclosporine or tacrolimus) toxicity, or mild vol-
ume contraction with decreased renal blood flow.
In the acute setting, increasing fluid intake with a
normalization of creatinine can thus help exclude
other, potentially more serious problems. This
commonly used strategy seems most relevant in
the early post-transplant months, when the risk
of acute rejection is highest, and immunosup-
pressive regimens are changing. Our results sug-
gest that increased oral fluid intake is a
reasonable strategy and appears safe, without
development of hyponatremia due to excessive
fluid intake.
While serum creatinine is an accepted marker
for renal function, assessing overall hydration
status is more problematic. In addition to record-
ing fluid intake, other studies have used daily
urine volume, or urine specific gravity. Twenty-
four-hour urine collections are inconvenient, and
if recorded at home, subject to the same limita-
tion as recording fluid intake. Urine specific
gravity in a healthy individual does reflect renal
free water clearance and thus overall hydration
status. Although it primarily varies in response
to fluid intake, however, it may be increased in
response to the action of calcineurin inhibitors,
or decreased in patients with chronic interstitial
fibrosis, making interpretation in transplant
recipients especially problematic. Only one study
has examined the effects of immunosuppressive
agents on renal free water clearance in transplant
recipients (8), showing that free water clearance
is reduced relative to healthy controls. This
results in decreased urine dilution, and thus
higher specific gravity, such that it is no longer
an effective marker for hydration state. In addi-
tion, free water clearance decreases with loss of
renal function (9), further limiting its usefulness
in this population.
It was interesting to note that the intervention
group tracked less than the control group. It may
be that the interactive feedback from the bottle
may have been enough or that it was challenging
to both manage the bottle and the tracking. We
also had many more participants who said they
tracked than turned in their tracking forms, mak-
ing it hard to determine the impact of tracking
on the intervention as well as the actual intake
reported. While tracking itself can be seen as an
intervention in and of itself (10), whether or not
participants tracked did not appear to impact
their laboratory values at Time 2 or change in
laboratory values over time. Ideally, a water bot-
tle that had the ability to download data would
be the best way to circumvent this issue, but
unfortunately that technology is not available at
this time. Many adherence interventions involve
tracking as a key to success (6); tracking may
have been a strong enough intervention in and of
itself to offset the benefits of using the program-
mable bottle.
Patient satisfaction with the use of the bottle
may have impacted its utility as an intervention
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tool. While most found it easy to use, this did
not universally translate into actual usage, with
only 50% of the group reporting using it every
day during the study and a third not using at all.
Given that this seemed to be a palatable interven-
tion for about half of the study group, further
information is needed on who tends to benefit
from this type of intervention. It is positive that
a strong majority felt comfortable using around
friends as children and adolescents may disre-
gard self-care to avoid calling attention to them-
selves or appearing “different” from peers (11).
The benefit to using a commercially available
product is that it anyone can purchase it and it
does not stand out as being something different
that would call attention to the child.
Description of study limitations
There are several limitations that should be taken
into account while interpreting these results. Pri-
marily, the reliance on patient self-report of fluid
intake because of the bottle’s inability to record
data introduces possible bias and may limit the
accuracy of the data. Specifically, there may have
been a bias toward reporting high numbers,
which may have skewed the self-report data,
especially as the participants had to share their
data with the clinic nurse coordinator. While
keeping a diary of adherence is a very promising
report strategy, families tend to overestimate
adherence and only about 50% of people keep
complete records (6). While our sample had a
higher response rate than typically reported in
the literature (6), lack of 100% response rate
decreased the amount of data for analysis. Fear
of sharing data with the clinic staff may have
impacted response rates. The use of a small, con-
venience sample may have impacted our ability
to detect results, particularly as our group likely
included youth with and without baseline fluid
adherence problems. The differences between
groups are very small and therefore not detect-
able with the small sample size. It is also possible
that the length of time in between Time 1 and 2
was not long enough for the laboratory values to
change substantially. While this is the standard
monitoring time for our clinic and reflects the
time period one would typically monitor a rec-
ommendation to increase fluid intake, a longer
Time 2 follow-up period would have likely led to
more robust findings. Lack of ethnic diversity in
our sample, while reflective of our clinic popula-
tion during the study period, is not reflective of
national trends in pediatric renal transplant and
may impact the generalization of findings to
other, more ethnically diverse populations (12).
Finally, while we had intended to have baseline
fluid intake, we were unable to gather that data
from the majority of the participants.
Clinical implications
As increasing fluid intake is often used as treat-
ment strategy for youth with kidney transplant,
using technology such as a commercially avail-
able interactive water bottle might help with
adherence to those recommendations for some
youth, particularly those who are interested in
and enjoy using such gadgets. Use of technology
has been shown to increase adherence in many
studies and needs further study as these technolo-
gies grow (13). Given the difficulty directly track-
ing data from the bottle, it will be important to
develop new technologies, such as a water bottle
that can track intake wirelessly or have the abil-
ity to maintain and download data. Finally, this
type of easily available technology might have
applications in other populations where tracking
fluid intake is important (e.g., encopresis, sickle-
cell disease, renal failure, heart failure, and he-
modialysis).
Future research
This pilot intervention focused on the goal set-
ting and information gathering aspects of adher-
ence while neglecting the decision making,
treatment-related action implementation, and
management of the emotional aspects of adher-
ence discussed by Creer (14). Future research
should consider adding in some of these more
complex aspects of fluid adherence in order to
more fully intervene with this clearly challenging
task. Any future research should employ gather-
ing baseline data that would allow future inter-
ventions to better target the aspects of adherence
for the individual child rather than having a one-
size fits all intervention (13). As noted earlier,
future research should control for and stratify
time since transplant given the impact of this var-
iable on outcomes reported here. Regardless, fur-
ther exploration of fluid adherence in pediatric
renal transplant is warranted.
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